Armata Pharmaceuticals, Inc.
DE ˙ DB ˙ US04216R1023
6,45 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:TG1N / Armata Pharmaceuticals, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership38,496 shares
Latest Disclosed Value $ 394,199
Renaissance Technologies Llc reports 43.80% decrease in ownership of TG1N / Armata Pharmaceuticals, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 38,496 shares of Armata Pharmaceuticals, Inc. (DE:TG1N) valued at $286,795 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 68,496 shares of Armata Pharmaceuticals, Inc.. This represents a change in shares of -43.80% during the quarter. The current value of the position is $248,299 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 38,496 -30,000 -43.80 394 -8.37 0.0006
2026-02-12 2025-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 68,496 27,200 65.87 430 249.59 0.0007
2025-11-13 2025-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 41,296 2,400 6.17 123 68.49 0.0002
2025-08-13 2025-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 38,896 300 0.78 74 30.36 0.0001
2025-05-14 2025-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 38,596 -1,695 -4.21 56 -24.32 0.0001
2025-02-13 2024-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 40,291 -6,205 -13.35 75 -32.73 0.0001
2024-11-13 2024-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 46,496 -1,700 -3.53 110 -16.67 0.0002
2024-08-09 2024-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 48,196 -3,200 -6.23 133 0.0002
2024-05-13 2024-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 51,396 -2,200 -4.10 0 0.0003
2024-02-13 2023-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 53,596 -3,900 -6.78 0 0.0003
2023-11-14 2023-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 57,496 -4,900 -7.85 0 0.0003
2023-08-11 2023-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 62,396 -800 -1.27 0 0.0001
2023-05-12 2023-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 63,196 -10,500 -14.25 0 0.0001
2023-02-13 2022-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 73,696 3,900 5.59 0 -100.00 0.0001
2022-11-14 2022-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 69,796 -10,200 -12.75 295 -5.14 0.0004
2022-08-12 2022-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 79,996 -1,700 -2.08 311 -22.06 0.0004
2022-05-13 2022-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 81,696 -3,100 -3.66 399 -14.19 0.0005
2022-02-11 2021-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 84,796 -21,296 -20.07 465 21.09 0.0006
2021-11-12 2021-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 106,092 -10,604 -9.09 384 -17.06 0.0005
2021-08-13 2021-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 116,696 -7,120 -5.75 463 -21.79 0.0006
2021-05-13 2021-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 123,816 24,820 25.07 592 100.68 0.0007
2021-02-10 2020-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 98,996 5,298 5.65 295 -1.34 0.0003
2020-11-13 2020-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 93,698 8,821 10.39 299 -10.21 0.0003
2020-08-13 2020-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 84,877 18,150 27.20 333 60.87 0.0003
2020-05-14 2020-03-31 13F ARMATA PHARMACEUTICALS COM 04216R102 66,727 -7,427 -10.02 207 -14.11 0.0002
2020-02-13 2019-12-31 13F ARMATA PHARMACEUTICALS COM 04216R102 74,154 -1,500 -1.98 241 -13.93 0.0002
2019-11-13 2019-09-30 13F ARMATA PHARMACEUTICALS COM 04216R102 75,654 800 1.07 280 -6.67 0.0002
2019-08-12 2019-06-30 13F ARMATA PHARMACEUTICALS COM 04216R102 74,854 -558,785 -88.19 300 57.07 0.0003
2019-05-14 2019-03-31 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 633,639 201,179 46.52 191 114.61 0.0002
2019-02-12 2018-12-31 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 432,460 218,600 102.22 89 -58.80 0.0001
2018-11-13 2018-09-30 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 213,860 50,900 31.23 216 17.39 0.0002
2018-08-13 2018-06-30 13F/A-1 AMPLIPHI BIOSCIENCES COM PAR 03211P301 162,960 37,600 29.99 184 34.31 0.0002
2018-08-13 2018-06-30 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 125,360 137
2018-05-14 2018-03-31 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 125,360 -13,000 -9.40 137 -2.14 0.0001
2018-02-13 2017-12-31 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 138,360 25,800 22.92 140 37.25 0.0002
2017-11-13 2017-09-30 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 112,560 -16,500 -12.78 102 0.99 0.0001
2017-08-11 2017-06-30 13F AMPLIPHI BIOSCIENCES COM PAR 03211P301 129,060 129,060 14.66 101 -0.98 0.0001
2017-05-12 2017-03-31 13F AMPLIPHI BIOSCIENCES COM NEW 03211P202 0 -70,000 -100.00 0 -100.00
2017-02-13 2016-12-31 13F AMPLIPHI BIOSCIENCES COM NEW 03211P202 70,000 53,100 314.20 31 19.23 0.0000
2016-11-14 2016-09-30 13F AMPLIPHI BIOSCIENCES COM NEW 03211P202 16,900 800 4.97 26 4.00 0.0000
2016-08-12 2016-06-30 13F AMPLIPHI BIOSCIENCES COM NEW 03211P202 16,100 16,100 25 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.